Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 28, 2016
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2016.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only indicates that such results were announced in a press release issued on July 28, 2016.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 8:30 AM EST on July 28, 2016, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the periods ended June 30, 2016.
- Verify the details of the conference call held on July 28, 2016, for management's outlook and commentary.
- Confirm whether the press release contains updated forward-looking guidance or risk factors.
- Check subsequent filings (e.g., 10-Q) for the audited or reviewed financial statements corresponding to this period.